Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer

被引:0
|
作者
Kentaro Sudo
Ryusuke Hara
Kazuyoshi Nakamura
Emiri Kita
Akiko Tsujimoto
Taketo Yamaguchi
机构
[1] Chiba Cancer Center,Department of Gastroenterology
[2] Chiba Cancer Center,Department of Radiation Oncology
来源
Cancer Chemotherapy and Pharmacology | 2017年 / 80卷
关键词
Pancreatic cancer; Gemcitabine; S-1; Chemoradiotherapy; Induction chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:195 / 202
页数:7
相关论文
共 50 条
  • [1] Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer
    Sudo, Kentaro
    Hara, Ryusuke
    Nakamura, Kazuyoshi
    Kita, Emiri
    Tsujimoto, Akiko
    Yamaguchi, Taketo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (01) : 195 - 202
  • [2] Gemcitabine and S-1 Induction Chemotherapy Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancers
    Maemura, Kosei
    Mataki, Yuko
    Kurahara, Hiroshi
    Kawasaki, Yota
    Iino, Satoshi
    Sakoda, Masahiko
    Uchikado, Yasuto
    Arigami, Takaaki
    Uenosono, Yoshikazu
    Mori, Shinichiro
    Ueno, Shinichi
    Shinchi, Hiroyuki
    Natsugoe, Shoji
    ANTICANCER RESEARCH, 2017, 37 (01) : 233 - 237
  • [3] A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer
    Nakachi, Kohei
    Furuse, Junji
    Kinoshita, Taira
    Kawashima, Mitsuhiko
    Ishii, Hiroshi
    Ikeda, Masafumi
    Mitsunaga, Shuichi
    Shimizu, Satoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 527 - 534
  • [4] A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer
    Kohei Nakachi
    Junji Furuse
    Taira Kinoshita
    Mitsuhiko Kawashima
    Hiroshi Ishii
    Masafumi Ikeda
    Shuichi Mitsunaga
    Satoshi Shimizu
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 527 - 534
  • [5] A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer
    Shinchi, Hiroyuki
    Maemura, Kosei
    Mataki, Yuko
    Kurahara, Hiroshi
    Sakoda, Masahiko
    Ueno, Shinichi
    Hiraki, Yoshiyuki
    Nakajo, Masayuki
    Natsugoe, Shoji
    Takao, Sonshin
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2012, 19 (02) : 152 - 158
  • [6] A Pilot Study for Combination Chemotherapy Using Gemcitabine and S-1 for Advanced Pancreatic Cancer
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Sasahira, Naoki
    Ito, Yukiko
    Kogure, Hirofumi
    Togawa, Osamu
    Matsubara, Saburo
    Arizumi, Toshihiko
    Yagioka, Hiroshi
    Yashima, Yoko
    Kawakubo, Kazumichi
    Mizuno, Suguru
    Yamamoto, Keisuke
    Hirano, Kenji
    Tsujino, Takeshi
    Ijichi, Hideaki
    Toda, Nobuo
    Tada, Minoru
    Kawabe, Takao
    Omata, Masao
    ONCOLOGY, 2009, 77 (05) : 300 - 303
  • [7] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
    Song, Hunho
    Han, Boram
    Park, Choong Kee
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Kim, In-Gyu
    Kim, Hyo Jung
    Jung, Joo Young
    Kim, Jung Han
    Kwon, Jung Hye
    Jang, Geundoo
    Kim, Ho Young
    Kim, Hyeong Su
    Choi, Dae Ro
    Zang, Dae Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 845 - 852
  • [8] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
    Hunho Song
    Boram Han
    Choong Kee Park
    Jong Hyeok Kim
    Jang Yong Jeon
    In-Gyu Kim
    Hyo Jung Kim
    Joo Young Jung
    Jung Han Kim
    Jung Hye Kwon
    Geundoo Jang
    Ho Young Kim
    Hyeong Su Kim
    Dae Ro Choi
    Dae Young Zang
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 845 - 852
  • [9] A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer
    Ueno, H
    Okusaka, T
    Ikeda, M
    Ishiguro, Y
    Morizane, C
    Matsubara, J
    Furuse, J
    Ishii, H
    Nagase, M
    Nakachi, K
    ONCOLOGY, 2005, 69 (05) : 421 - 427
  • [10] S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer
    Ke, Qing-Hua
    Zhou, Shi-Qiong
    Yang, Ji-Yuan
    Du, Wei
    Liang, Gai
    Lei, Yong
    Luo, Fei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (38) : 13987 - 13992